Your browser doesn't support javascript.
loading
Hypertriglyceridemia-induced acute necrotizing pancreatitis: Poor clinical outcomes requiring revisiting management modalities.
Abboud, Yazan; Shah, Meet; Simmons, Benjamin; Mandava, Kranthi; Morales, John E M; Jaber, Fouad; Alsakarneh, Saqer; Ismail, Mohamed; Hajifathalian, Kaveh.
Afiliação
  • Abboud Y; Department of Internal Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
  • Shah M; Department of Internal Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
  • Simmons B; Department of Internal Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
  • Mandava K; Department of Internal Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
  • Morales JEM; Department of Internal Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
  • Jaber F; Department of Internal Medicine University of Missouri-Kansas City Kansas City Missouri USA.
  • Alsakarneh S; Department of Internal Medicine University of Missouri-Kansas City Kansas City Missouri USA.
  • Ismail M; Department of Internal Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
  • Hajifathalian K; Division of Gastroenterology and Hepatology Rutgers New Jersey Medical School Newark New Jersey USA.
JGH Open ; 8(4): e13061, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38617108
ABSTRACT
Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is the third most common cause of AP after gallstones and alcohol. Supportive measures, intravenous insulin, and plasmapheresis are possible treatment modalities for HTG-AP; however, definitive guidelines evaluating the best therapeutic approach are not clearly established. We present a rare case of a 42-year-old male without known comorbidities who was found to have HTG-AP. Despite early initiation of intravenous insulin and plasmapheresis and the initial decline in his triglycerides level, his condition was complicated by necrotizing pancreatitis and subsequent multi-organ failure. Future studies are warranted to evaluate the role of plasmapheresis in HTG-AP and its efficacy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article